CA3167694A1 - Score de prevalence genomique panomique - Google Patents

Score de prevalence genomique panomique Download PDF

Info

Publication number
CA3167694A1
CA3167694A1 CA3167694A CA3167694A CA3167694A1 CA 3167694 A1 CA3167694 A1 CA 3167694A1 CA 3167694 A CA3167694 A CA 3167694A CA 3167694 A CA3167694 A CA 3167694A CA 3167694 A1 CA3167694 A1 CA 3167694A1
Authority
CA
Canada
Prior art keywords
determined
features selected
carcinoma
nos
biosignature indicative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3167694A
Other languages
English (en)
Inventor
Jim ABRAHAM
David Spetzler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Caris Life Sciences Inc
Original Assignee
Caris MPI Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Caris MPI Inc filed Critical Caris MPI Inc
Priority claimed from PCT/US2021/018263 external-priority patent/WO2021163706A1/fr
Publication of CA3167694A1 publication Critical patent/CA3167694A1/fr
Pending legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Un profilage moléculaire complet fournit une richesse de données concernant l'état moléculaire d'échantillons de patient. De telles données peuvent être comparées à une réponse de patient à des traitements pour identifier des signatures de biomarqueurs qui prédisent une réponse ou une non réponse à de tels traitements. Selon l'invention, des données de profilage moléculaire ont été utilisées pour identifier des signatures de biomarqueurs (biosignatures) qui prédisent une lignée primaire de tumeur, une catégorie ou un type de cancer, un groupe d'organes et/ou une histologie d'organes. La signature peut utiliser des informations de niveau génomique et de transcriptome.
CA3167694A 2020-02-14 2021-02-16 Score de prevalence genomique panomique Pending CA3167694A1 (fr)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US62/977,015 2020-02-14
US202063014515P 2020-04-23 2020-04-23
US63/014,515 2020-04-23
US202063052363P 2020-07-15 2020-07-15
US63/052,363 2020-07-15
US202163145305P 2021-02-03 2021-02-03
US63/145,305 2021-02-03
PCT/US2021/018263 WO2021163706A1 (fr) 2020-02-14 2021-02-16 Score de prévalence génomique panomique

Publications (1)

Publication Number Publication Date
CA3167694A1 true CA3167694A1 (fr) 2021-08-19

Family

ID=83688525

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3167694A Pending CA3167694A1 (fr) 2020-02-14 2021-02-16 Score de prevalence genomique panomique

Country Status (1)

Country Link
CA (1) CA3167694A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220138935A1 (en) * 2020-11-04 2022-05-05 Samsung Sds America, Inc. Unsupervised representation learning and active learning to improve data efficiency
CN114507738A (zh) * 2022-03-25 2022-05-17 苏州药诺泰克新药研发有限公司 甲基化位点、检测甲基化水平的产品的用途及试剂盒
CN114540498A (zh) * 2022-03-09 2022-05-27 厦门飞朔生物技术有限公司 一种基于dna甲基化的浸润性神经胶质瘤的分类装置
CN114717319A (zh) * 2022-04-19 2022-07-08 南京世和基因生物技术股份有限公司 用于胆管癌预后评估的基因标志物
CN116246705A (zh) * 2023-05-10 2023-06-09 国家食品安全风险评估中心 全基因组测序数据的分析方法和装置

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220138935A1 (en) * 2020-11-04 2022-05-05 Samsung Sds America, Inc. Unsupervised representation learning and active learning to improve data efficiency
CN114540498A (zh) * 2022-03-09 2022-05-27 厦门飞朔生物技术有限公司 一种基于dna甲基化的浸润性神经胶质瘤的分类装置
CN114507738A (zh) * 2022-03-25 2022-05-17 苏州药诺泰克新药研发有限公司 甲基化位点、检测甲基化水平的产品的用途及试剂盒
CN114717319A (zh) * 2022-04-19 2022-07-08 南京世和基因生物技术股份有限公司 用于胆管癌预后评估的基因标志物
CN116246705A (zh) * 2023-05-10 2023-06-09 国家食品安全风险评估中心 全基因组测序数据的分析方法和装置

Similar Documents

Publication Publication Date Title
US11315673B2 (en) Next-generation molecular profiling
US11842805B2 (en) Pan-cancer platinum response predictor
US20200024669A1 (en) Genomic stability profiling
US20230178245A1 (en) Immunotherapy Response Signature
CA3167694A1 (fr) Score de prevalence genomique panomique
US20220093217A1 (en) Genomic profiling similarity
US20230113092A1 (en) Panomic genomic prevalence score
US20230368915A1 (en) Metastasis predictor
JP7526188B2 (ja) ゲノムプロファイリングの類似性
US20240254559A1 (en) Genomic stability profiling
JP2024102046A (ja) 次世代分子プロファイリング